Buccal, polar and non-polar spray containing zolpidem

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S045000, C514S923000

Reexamination Certificate

active

07632517

ABSTRACT:
Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide zolpidem for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, zolpidem, and optional flavoring agent; formulation II: aqueous polar solvent, zolpidem, optionally flavoring agent, and propellant; formulation III: non-polar solvent, zolpidem, and optional flavoring agent; formulation IV: non-polar solvent, zolpidem, optional flavoring agent, and propellant; formulation V: a mixture of a polar solvent and a non-polar solvent, zolpidem, and optional flavoring agent; formulation VI: a mixture of a polar solvent and a non-polar solvent, zolpidem, optional flavoring agent, and propellant.

REFERENCES:
patent: 3304230 (1967-02-01), Abramson et al.
patent: 3784684 (1974-01-01), Bossert et al.
patent: 4232002 (1980-11-01), Nogrady
patent: 4495168 (1985-01-01), Schmolka
patent: 4689233 (1987-08-01), Dvorsky et al.
patent: 4704406 (1987-11-01), Stanislaus et al.
patent: 4755389 (1988-07-01), Jones et al.
patent: 4814161 (1989-03-01), Jinks et al.
patent: 4857312 (1989-08-01), Hegasy et al.
patent: 4863720 (1989-09-01), Burghart et al.
patent: 4863970 (1989-09-01), Patel et al.
patent: 4919919 (1990-04-01), Aouda et al.
patent: 4935243 (1990-06-01), Borkan et al.
patent: 5011678 (1991-04-01), Wang et al.
patent: 5047230 (1991-09-01), Nagy et al.
patent: 5128132 (1992-07-01), Parnell
patent: 5135753 (1992-08-01), Baker et al.
patent: 5143731 (1992-09-01), Viegas et al.
patent: 5166145 (1992-11-01), Jao et al.
patent: 5186925 (1993-02-01), Cholcha
patent: 5240932 (1993-08-01), Morimoto et al.
patent: 5290540 (1994-03-01), Prince et al.
patent: 5364616 (1994-11-01), Singer et al.
patent: 5370862 (1994-12-01), Klokkers-Bethke et al.
patent: 5428006 (1995-06-01), Bechgaard
patent: 5456677 (1995-10-01), Spector
patent: 5457100 (1995-10-01), Daniel
patent: 5474759 (1995-12-01), Fassberg et al.
patent: 5502076 (1996-03-01), Dixit et al.
patent: 5519059 (1996-05-01), Sawaya
patent: 5593684 (1997-01-01), Baker et al.
patent: 5602182 (1997-02-01), Popli et al.
patent: 5605674 (1997-02-01), Purewal et al.
patent: 5607915 (1997-03-01), Patton
patent: 5635161 (1997-06-01), Adjei et al.
patent: 5645856 (1997-07-01), Lacy et al.
patent: 5719197 (1998-02-01), Kanios et al.
patent: 5725841 (1998-03-01), Duan et al.
patent: 5766573 (1998-06-01), Purewal et al.
patent: 5795909 (1998-08-01), Shashoua et al.
patent: 5824307 (1998-10-01), Johnson
patent: 5869082 (1999-02-01), Dugger, III
patent: 5891465 (1999-04-01), Keller et al.
patent: 5906811 (1999-05-01), Hersh
patent: 5908611 (1999-06-01), Gottlieb et al.
patent: 5955098 (1999-09-01), Dugger, III
patent: 5981591 (1999-11-01), Deihl
patent: 6071539 (2000-06-01), Robinson et al.
patent: 6110486 (2000-08-01), Dugger, III
patent: 6143329 (2000-11-01), Kim
patent: 6212227 (2001-04-01), Ko et al.
patent: 6258032 (2001-07-01), Hammesfahr
patent: 6271240 (2001-08-01), Simon
patent: 6299900 (2001-10-01), Reed et al.
patent: 6375975 (2002-04-01), Modi
patent: 6458842 (2002-10-01), Dickinson et al.
patent: 6512002 (2003-01-01), Lee et al.
patent: 6676931 (2004-01-01), Dugger
patent: 6706255 (2004-03-01), Dickinson et al.
patent: 6816452 (2004-11-01), Machata
patent: 6969508 (2005-11-01), Dugger, III
patent: 6977070 (2005-12-01), Dugger, III
patent: 6998110 (2006-02-01), Dugger, III
patent: 7202233 (2007-04-01), Penkler
patent: 2003/0077227 (2003-04-01), Dugger
patent: 2003/0082107 (2003-05-01), Dugger
patent: 2004/0136913 (2004-07-01), Adb El-Shafy et al.
patent: 2004/0141923 (2004-07-01), Dugger et al.
patent: 2006/0222597 (2006-10-01), Dugger et al.
patent: 2007/0048229 (2007-03-01), Dugger et al.
patent: 3338978 (1984-05-01), None
patent: 3246081 (1984-06-01), None
patent: 4007705 (1991-09-01), None
patent: 4038203 (1992-06-01), None
patent: 4112303 (1992-10-01), None
patent: 4132176 (1993-04-01), None
patent: 0140434 (1985-05-01), None
patent: 0213 108 (1987-03-01), None
patent: 0315960 (1989-05-01), None
patent: 0386700 (1990-09-01), None
patent: 0471161 (1992-02-01), None
patent: 0504112 (1992-09-01), None
patent: 0605483 (1993-04-01), None
patent: 0557129 (1993-08-01), None
patent: 0656206 (1995-06-01), None
patent: 0719549 (1996-07-01), None
patent: 1029536 (2000-08-01), None
patent: 2633933 (1990-01-01), None
patent: 2082457 (1982-03-01), None
patent: 2295318 (1996-05-01), None
patent: 912509 AI (1992-02-01), None
patent: 02-026661 (1990-01-01), None
patent: WO 90/01046 (1990-02-01), None
patent: WO 93/03751 (1993-03-01), None
patent: WO93/04671 (1993-03-01), None
patent: WO 94/10987 (1994-05-01), None
patent: WO94/13280 (1994-06-01), None
patent: WO95/24893 (1995-09-01), None
patent: WO 95/31217 (1995-11-01), None
patent: WO 97/38662 (1997-10-01), None
patent: WO 97/38663 (1997-10-01), None
patent: WO 97/38687 (1997-10-01), None
patent: WO 98/29097 (1998-07-01), None
patent: WO 98/52540 (1998-11-01), None
patent: WO 98/52545 (1998-11-01), None
patent: WO 99/16417 (1999-04-01), None
patent: WO 00/06534 (2000-02-01), None
patent: WO 00/27359 (2000-05-01), None
patent: WO 00/62757 (2000-10-01), None
patent: WO 01/66089 (2001-09-01), None
patent: WO 02/43695 (2002-06-01), None
patent: WO 02/066089 (2002-08-01), None
patent: WO 02/094232 (2002-11-01), None
patent: WO 02/094234 (2002-11-01), None
Cassidy, et al, Journal of Controlled R2/8/2007elaese, 25 (1993) 21-29, Controlled buccal delivery of buprenorphine.
Physician's Desk Reference, 49thEdition, 1995, p. 2304-2306.
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., pp. 490.
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., pp. 496.
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., pp. 497.
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., pp. 471-472.
Drug Facts and Comparisons(Jan. 2002) pp. 186c-186d.
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., (1996), pp. 141-154, 169-170, 260, 303-304, 324, 362, 372, 420-422, 427, 471, 472, 478-480, 484, 490, 496-497, 928-930.
Karlsson, et al.; “A Comparison of the Effect of Inhaled Diuretics on Airway Reflexes in Humans and Guinea Pigs”,The American Physiological Society, pp. 434-438 (1992).
L.W. Brox, et al.; “Studies on the Growth Inhibition and Metabolism of 2′-Deoxy-2′ fluorocytidine in Cultured Human Lymphoblasts”;Cancer Research, vol. 34, pp. 1838-1842 (1974).
Maarek et al., “The Safety and Efficacy of Zolpidem in Insomniac Patients: a Long-Term Open Study in General Practice,” J. Int. Med. Res., 1992, 2092), 162-170.
Mochizuki, et al.; Inhaled Diuretics Attenuate Acid-Induced Cough in Children With Asthma; Chest, 107/2 pp. 413-417 (1995).
Physician's Desk Reference, 1995, pp. 858-861, 2436-2441, 2548-2550.
Schlich, D., et al., “Long-terma treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients.” The Journal of International Medical Research, 1991, 19(3), pp. 271-279.
Ting-Chao Chou, et al.; “Pharmacological Disposition and Metabolic Fate of 2′-Fluoro-5-iodo-1-β-D-arabinofuranosylcytosine in Mice and Rats”; Cancer Research, vol. 41, pp. 3336-3342 (1981).
Woodley et al., Manual of Medical Therapeutics, 27th Edition, 1992, pp. 341 and 370-371.
Written Opinion of the International Searching Authority—Feb. 28, 2006.
Ye, Jiang Hong et al.; “Ondansetron Exhibits The Properties of a Local Anesthetic”; Anesthesia and Analgesia, vol. 85. No. 5, Nov. 1997; pp. 1116-1121.
Zervakis, et al.; “Taste Effects of Lingual Application of Cardiovascular Medications”; Physiology & Behavior, 68: pp. 405-413 (2000).
Cosdon, Christina K., “Sprays sold as better way to get vitamins,”Seminole Times; Seminole Business Digest, Nov. 6, 1996.
Shojaei, Amir H., “Buccal Mucosa as a Route for Systemic Drug Delivery: A Review”,J Pharm Pharmaceut Sci, 1(1)

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Buccal, polar and non-polar spray containing zolpidem does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Buccal, polar and non-polar spray containing zolpidem, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buccal, polar and non-polar spray containing zolpidem will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4134374

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.